Brazil Artificial Organs & Bionic Implants Market

The Brazil Artificial Organs & Bionic Implants Market size was valued at USD XX Billion in 2022 and is expected to surpass USD XX Billion by 2031, expanding at a CAGR of 11.69% during the forecast period, 2023 – 2031. The growth of the market is attributed to growing elderly population and unhealthy lifestyle bringing various diseases such as cardiac arrest, liver sorosis and others also rising instances of accidents.

When an organ in a person's body is destroyed due to accident or disease, organ transplantation becomes necessary. However, there are much fewer organ donors than there are people who need them. Although there is a potential that the transplanted organ will be rejected once it has been implanted. This indicates that the recipient's immune system is unable to accept the organ.

Get Free Sample Report

The market size for artificial organs and bionic implants is now being pushed by the fact that a huge number of patients require organ transplantation, despite the fact that not everyone can receive an organ due to a lack of donors.

According to the Brazilian Association of Organ Transplantation (ABTO)— number of donors in Brazil is sixteen donors on per million individuals. The average waiting period for a kidney transplant from a dead donor is three years.

According to survey conducted by Med Plus in Brazil infectious infections (30.2%), family rejection (37.2%), and clinical contraindications were the most common reasons for non-donation (32.6 percent). The majority of potential donors were overlooked in the middle of the night (54.8 percent) and at the emergency room (80.9 percent).

According to the Brazilian Dialysis Census of July 2018, the total number of dialysis patients was predicted to be 133,464, with a prevalence rate of 640 patients per million people (pmp). 92.3 % of the patients on dialysis were on hemodialysis, 7.7% were on peritoneal dialysis, and 29,545 (22.1 percent) were on the transplant waiting list.

Recent developments in the disciplines of artificial organs and regenerative medicine are now coming together in the realms of organ transplantation and bioengineering to help patients with end-stage renal illness overcome ongoing hurdles.

The transplantable bioengineered kidney with the implanted artificial renal assist device (RAD). Micromachining methods are used in the artificial RAD concept to create a biohybrid system that can imitate renal shape and function.

Hearing devices that measure physical activity and detect falls are being developed by Starkey Hearing Technologies. It's also developing new sensors, such as heart rate monitors, as a first step in bringing hearing aids into the realm of health and wellness.

Surface modification of titanium implants for enhancing the corrosion resistance and related properties of biomaterials are focus of manufactures as
On March 2021, The US Patent Office gave permission of patent No. 10,933,183 for the updated version of the wearable artificial organs (WAK) according to Victor Gura, MD, chairman and chief scientific officer of Wearable Artificial Organs Inc. Patients with end-stage renal disease are hampered by current fixed dialysis devices, which limit their mobility and activity.

The new gadget is significantly lighter and smaller than the 1.0 and 2.0 generations. Three clinical studies in Vicenza, Italy, London, United Kingdom, and Seattle, Washington, successfully tested the proof-of-concept model 2.0, an 11-pound device. The WAK 3.0 is 2 pounds in weight and runs on a rechargeable battery.

Covid 19 has affected the market negatively as governments announced national emergency in the country leads to delay or halt all the surgeries as it increases the risk of exposure for the virus into the patient.

Market Trends, Drivers, Restraints, and Opportunities

• Rising elderly population is expected to boost the market during the forecast period.

• Introduction of portable implant devices is projected to drive the market in the coming years.

• Absence of organ donors and increasing instances of organ failure are anticipated to fuel the market.

• Growing burden of diseases, unhealthy life styles and poor dietary among population are expected to spur the market in the coming years.

• Rising accidents causing organ damage or physical disabilities is estimated to fuel the market.

• Increasing cases of genetic disorders is anticipated to push the market.

• Organ implant is a very high-cost procedure which act as key challenges that can hamper the market growth.

• Organ rejection patients’ body after organ implantation is the major factor to restrict the market.

• Technological advancements in genetic engineering and biomedicals are creating a significant opportunity for the market players.

Scope of the Report

The report on the Brazil artificial organs & bionic implants market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Brazil Artificial Organs & Bionic Implants Market Segment Insights

The cardiac bionics segment is projected to hold a large market share

Based on products, the Brazil artificial organs & bionic implants market is divided into artificial organs, and bionics. The bionics segment is further segmented into orthopedic bionic, vision bionics, cardiac bionics, and others. The cardiac bionics expected to account for a key share of the market during the forecast period owing to increasing load of chronic heart diseases also they are cost effective and less chances of organ rejection are there.

Get Free Sample Report

Segments

The Brazil artificial organs & bionic implants market has been segmented on the basis of

Products

• Artificial Organs
  • Artificial Kidney
  • Artificial Heart
  • Others
• Bionics
  • Orthopedic Bionic
  • Vision Bionics
  • Cardiac Bionics
  • Others

Country

• Brazil

Key Players

• Medtronic plc
• Ottobock
• Zimmer Biomet
• Ossur
• Boston Scientific Corporation

Competitive Landscape

Key players competing in the Brazil artificial organs & bionic implants market include Medtronic plc; Ottobock; Zimmer Biomet; Ossur; Boston Scientific Corporation.

Some of these players are focusing on business strategies including partnerships, collaborations, capacity expansion, and product launches to increase their market shares.